Empowered Patient Radio-logo

Empowered Patient Radio

Health, Home & Life >

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.
More Information

Location:

San Diego, CA

Description:

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.

Twitter:

@karenjagoda

Language:

English


Episodes

Using Cellular Therapies to Treat Neurodegenerative Diseases with Dr. Ralph Kern BrainStorm Cell Therapeutics

9/18/2019
More
Dr. Ralph Kern, Chief Medical Officer, BrainStorm Cell Therapeutics talks about their late stage clinical programs in treating ALS and MS using stem cells derived from bone marrow as well as the promise of using their technology platform to manufacture the cells to develop therapies for other neurodegenerative diseases like Parkinson's and Huntington's Disease and autism. While not a cure, this therapy using repair molecules is focused on stabilizing and preventing further...

Duration:00:16:02

Using Virtual Reality to Treat Chronic Pain with Lincoln Nguyen Karuna Labs

9/16/2019
More
Lincoln Nguyen, CEO, Karuna Labs discusses their work in pain management using virtual reality to build immersive environments to aid in retraining the brain to overcome learned pain behaviors. Of particular concern is the fear of movement of those suffering from chronic pain and addressing real dangers for additional injury and those that are threat signals from the brain related to the original cause of the pain. Since opioids have not proven to help chronic pain long term, innovations...

Duration:00:16:46

Advances in Stem Cell Therapies with Sean Berman Cell Surgical Network

9/11/2019
More
Sean Berman, Cell Surgical Network talks about the advances in stem cell therapies that are allowing doctors to treat orthopedic conditions and inflammatory diseases. He describes how stem cells are isolated and harvested and in turn used in therapies for many parts of the body. Still being tested in clinical trials, stem cell therapies have become more accepted and considered an option earlier in a treatment plan. Cell Surgical Network Download the transcript here

Duration:00:15:32

Developing Novel Therapy for Hemophilia with Nassim Usman Catalyst Biosciences

9/10/2019
More
Nassim Usman, CEO, Catalyst Biosciences discusses the problem of Hemophilia, a rare disease in which patients have a genetic deficiency in their ability to prevent bleeding. Currently, these patients must receive cumbersome bi-weekly IV infusions of clotting factor replacement therapy and may still bleed. Catalyst is developing a solution to give these patients a better and more convenient treatment particularly for inhibitor patients who have developed antibodies to their replacement...

Duration:00:15:30

Remote Patient Monitoring and Innovations in Sensors with Sam Liu VivaLNK

9/4/2019
More
Sam Liu, Vice President Marketing, VivaLNK talks about the current state of health wearables and how they are powering the growth of remote patient monitoring (RPM), how continuous monitoring changes the relationship between doctors and patients, and advances in sensors which will make it easier for patients to comply with reporting and treatment plans. @viva_LNK VivaLNK.com Download the transcript here.

Duration:00:17:10

Fluid Monitoring Innovation Dramatically Improves Patient Outcome with Chris Hutchison Cheetah Medical

8/28/2019
More
Chris Hutchison, CEO, Cheetah Medical discusses the importance of a non-invasive, easy to use way to assess if a patient will respond positively to IV fluids in emergencies and in other critical care situations, and how Cheetah Medical devices are empowering healthcare providers by providing real time, continuous information to allow them to dose fluids safely, dynamically and with confidence they are doing no harm. @Cheetah_Medical #IVFluid #FluidManagement #sepsis #criticalcare Cheetah...

Duration:00:14:39

Controlling the Immune System with Alexis Peyroles OSE Immunotherapeutics

8/26/2019
More
Alexis Peyroles, CEO, OSE Immunotherapeutics talks about the important role the immune system plays in the development of a number of diseases. OSE is a biotechnology company focused on the therapies that control the immune system for treatment of cancers and autoimmune diseases. We discuss how drugs that regulate the immune system can provide the basis for the next generation of oncology and autoimmune disease treatments. @OSEImmuno #autoimmune #ImmunoOncology #Oncology #OSE_IMMUNO OSE...

Duration:00:15:54

Advanced Non-Invasive Treatment for Headaches with Dr. Tony Fiorino electroCore

8/19/2019
More
Dr. Tony Fiorino, Chief Medical Officer, electroCore discusses the challenge of managing and preventing primary and secondary headaches particularly migraines, the science behind the electroCore non-invasive vagus nerve stimulator gammaCore and understanding the neurological triggers and mechanisms of headache disorders. @electroCoreVNS #migraine #headaches #neuromodulation #non-invasive #vagusnervestimulation #neurology electroCore.com Download the transcript here.

Duration:00:16:37

Dramatic Advances in Brain Surgery with Dr. Costas Hadjipanayis Mount Sinai Beth Israel Hospital

8/12/2019
More
Dr. Costas Hadjipanayis, Director of Neurosurgical Oncology for Mount Sinai Beth Israel Hospital discusses his experience working with the advanced robotically-controlled digital microscope, Modus V, from Synaptive Medical and how this technology was used recently to successfully remove a 19-year old woman's rare brain tumor. Dr. H talks about the advantages to using this technology prior to surgery and during surgery, and how doctors need to think about embracing new devices and techniques...

Duration:00:16:45

Developing Combination Therapies to Attack Cancer with Isaac Israel Kitov Pharmaceuticals

8/7/2019
More
Isaac Israel, CEO, Kitov Pharmaceuticals talks about how the development of new cancer treatments is an active and rapidly changing field and how Kitov is focusing on making cancer treatments more effective for patients. They are developing combination therapies that can help overcome cancers' ability to develop resistance to treatment. Kitov is working on two innovative cancer treatments soon to be advanced to clinical trials. #oncology #immunoOncology Kitov Pharmaceuticals Download the...

Duration:00:16:14

Gastrointestinal Diseases and Overcoming Antibiotic Resistance with Gilead Raday Redhill Biopharma

7/30/2019
More
Gilead Raday, COO, Redhill Biopharma, a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases talks about the growing problem of antibiotic resistance and the challenges this presents treating H. pylori infections, which affects about half of the global population. Redhill is working to bring Talicia, a new treatment for H. pylori to market potentially this year giving patients a new effective option for H. pylori infection. #RDHL $RDHL #Hpylori #IBD...

Duration:00:15:41

Decentralizing Research and Development of Molecular Compounds with Paul Kohlhaas Molecule

7/22/2019
More
Paul Kohlhaas, Founder, Molecule is passionate about creating a network for the decentralization of the process of researching new molecules and developing new molecular compounds using blockchain to track and reward all those who participate. With the current pharma innovation crisis and rising costs of drug development, new methods are needed to break down silos and overcome challenges of drug resistance and treating rare diseases. @molecule_to Molecule.to Download the transcript here.

Duration:00:14:52

Novel Treatment for Rare Neuroendocrine Diseases with Dr. Nerissa Kreher Tiburio

7/16/2019
More
Dr. Nerissa Kreher, Chief Medical Officer, Tiburio discusses the company's lead asset, TBR-760 as a novel treatment option for patients with non-functioning pituitary adenomas (NFPA), which are rare neuroendocrine tumors located in the pituitary gland. She also speaks about the challenges facing patients even after surgical or radiation treatments for these pituitary tumors. @TiburioT #neuroendocrine #pituitaryadenoma #chiefmedicalofficer #raredisease #NFPA Tiburio Therapeutics Download...

Duration:00:15:45

Skin Microbiome Targeted to Tackle Treatment-Resistant Dermatological Conditions with Venkat Nelabhotla Vyome Therapeutics

7/10/2019
More
Venkat Nelabhotla, Chief Executive Officer, Vyome Therapeutics discusses the growing problem of antimicrobial resistance in medicine and how Vyome is working to tackle resistant dermatological conditions using their understanding of the skin microbiome. Focusing first on acne, Vyome is developing VB-1953, a topical gel capable of killing resistant strains of P. acnes to help deliver solutions to the more than 10 million patients in the US, and more world-wide, with antibiotic resistant...

Duration:00:14:43

Enhancing Chemo and Radiation for Prostate Cancer with Dr. Greg van Wyk Noxopharm

6/25/2019
More
Dr. Greg van Wyk, CMO and recently appointed CEO, Noxopharm talks about the Company's current milestones and upcoming news related to its lead clinical drug candidate, Veyonda, a chemotherapy and radiation enhancer that is being studied in men with late stage metastatic prostate cancer and that may have broad applicability in other cancer types. Greg notes the explosion of mergers and acquisitions particularly in the oncology space due to increasing interest in combining one or more...

Duration:00:17:08

Empowering People Impacted by Cancer with Terri Wingham A Fresh Chapter

6/19/2019
More
Terri Wingham, Founder, A Fresh Chapter was diagnosed with an aggressive form of cancer when she was in her 30's. As a result she founded A Fresh Chapter, giving cancer survivors and caregivers an opportunity to travel to foreign and US destinations to get outside of their comfort zone and discover new possibilities, community and purpose. These odysseys are supplemented by online resources and financial underwriting from corporate sponsors including Eli Lilly. @afreshchapter #cancer A...

Duration:00:16:30

Targeting Gastrointestinal Disorders and Related Pain with Dr. Preston Klassen Arena Pharmaceuticals

6/12/2019
More
Preston Klassen, MD Chief Medical Officer, Arena Pharmaceuticals talks about the challenges of treating Inflammatory Bowel Diseases (IBD) and Arena's developmental therapies for ulcerative colitis and Crohn's disease. We also talk about the development of a treatment for related gastrointestinal pain with a non-opioid alternative. #Arena #Ulcerativecolitis #GI #IBD #crohns @ArenaPharm Arena Pharmaceuticals Arena Pharmaceuticals

Duration:00:17:31

Unique Therapy for Multiple Inflammatory Diseases with Dr. Jean-Marc Steens Abivax

6/4/2019
More
Dr. Jean-Marc Steens, Chief Medical Officer, Abivax reports on clinical results that continue to show advances in the chronic treatment and maintenance of moderate to severe ulcerative colitis using a new small molecule ABX464 in an oral treatment and potential applications for other inflammatory and neurological diseases. Jean-Marc also explains how another molecule ABX196 is being tested to determine if it might increase the outcome of treatments for hepatocellular carcinoma, the most...

Duration:00:16:44

Developing a Therapeutic Vaccine for Celiac Disease with Bob Anderson ImmusanT

5/28/2019
More
Bob Anderson PhD, Chief Scientific Officer, ImmusanT is an internationally recognized leader in celiac disease research. He talks about the underlying causes of celiac, who is most likely to have an acquired immune response to fragments of the gluten protein, educating doctors about the need to test for celiac, the Phase 2 clinical trial results for Nexvax2 a therapeutic vaccine to treat celiac, and how the ImmusanT platform technology is allowing development of therapeutic vaccines for...

Duration:00:18:21

Implications of First Imaging Biomarker for PTSD with Dr. Amit Etkin Stanford School of Medicine

5/14/2019
More
Amit Etkin MD PhD is a professor of psychiatry and behavioral sciences at the Stanford School of Medicine and expert in the neural basis of emotional disorders. He talks about a recent study published in Science Translational Medicine, of which he was the lead author physician, on his research that lead to the discovery of the first imaging biomaker for PTSD. Using fMRI and TMS with EEG, Amit was able to identify which patients were most likely to be helped by different treatment plans for...

Duration:00:16:22